Serenity
AI & Semiconductor Supply-Chain Researcher, Trader
Aehr Test Systems is growing fast across several verticals, with its lead AI processor customer placing another $22M follow-on order for wafer-level burn-in systems. The tiny company is expanding into memory and silicon photonics as well, and at about $1.1B market cap it looks extremely promising, resembling an early Teradyne. x.com
Aehr Test Systems' 2027 guidance of $130–150M, 160–200% growth, likely understates revenue if its customers convert to high-volume manufacturing. It assumes little or no memory revenue or revenue from a newly benchmarked AI customer, a major AI accelerator supplier whose benchmark beat expectations. The lead AI processor customer is ramping significantly, a NAND flash leader is weighing an HBM/NAND development deal, and Q4 bookings were $60.7M with $100.6M effective backlog. It is very volatile. x.com
Aehr Test Systems stands to benefit from Broadcom's custom AI chip ramp because these 600W–2kW multi-die packages need burn-in testing. Broadcom said XPU shipments rose 3.5x and laid out $115B of AI revenue in FY27 and $230B in FY28 with supply secured, backed by multi-gigawatt Google, Anthropic, OpenAI and Meta deployments. Aehr won a record $41M package-level burn-in order from its lead hyperscale customer for a custom AI ASIC, with a next-gen device moving to production later this year. x.com
Aehr Test Systems' AI wafer-level burn-in business is scaling, with a $22M follow-on order from its lead AI processor customer to expand capacity for high-volume production. That customer is already planning more capacity, and Aehr is expanding talks with other hyperscalers. The stock reached fresh all-time highs, and its recent strength looks like institutional accumulation. x.com x.com x.com
Aehr remains a concentrated, expensive way to own wafer-level photonics burn-in: its 10-K says silicon-photonics customers primarily drove that revenue growth, and FY2027 guidance of $130m-$150m could nearly triple FY2026 sales, yet shares value it at about 20x the guide. Teradyne's acquired photonic-chip test business is not material to its much larger sales; Aehr's top five customers provided 70% of FY2026 revenue, so orders matter more than the headline CPO opportunity. x.com
Aehr Test Systems' lead hyperscale customer is expanding production with about $6M of follow-on Sonoma orders for a second-generation AI processor. These are production-capacity orders, not evaluations, and the customer expects the second processor eventually to exceed the volumes of the first, already in high-volume production. Teradyne's new burn-in on Titan HP overlaps only with package-level Sonoma work, not FOX-XP wafer-level burn-in that screens dies before costly CoWoS packaging. x.com
Aehr Test Systems has validated its burn-in thesis as bookings convert to revenue and evaluation customers move into production, with AI processor power, silicon photonics and hybrid bonding raising the value of burn-in testing. Q4 bookings rose to $60.7M from $11.1M, effective backlog reached $100.6M, twice fiscal 2026 revenue, and fiscal 2027 guidance of $130M-$150M implies 160%-200% growth. The results lead optical production and could renew momentum in the optical theme. x.com x.com x.com … Show more
Aehr Test Systems is a case of narrative running ahead of the numbers. The bull case is reasonable: a young company with a strong position in silicon carbide burn-in, genuine hyperscaler interest in AI chip burn-in and room to expand into memory and logic. But the latest quarter showed revenue down 43% year over year, with no meaningful order conversion from the AI opportunities yet. Until revenue improves and orders come through more clearly, the story stays ahead of the fundamentals. x.com
Aehr's AI burn-in growth case is intact, but confidence in its competitive edge may need to come down as Teradyne moves into high-power burn-in. Teradyne's Titan HP, already in production, combines system-level test and burn-in and could absorb spending on dedicated tools, pressuring Sonoma orders and pricing. Aehr still won about $6M of follow-on Sonoma orders for a hyperscaler's second AI chip, with no sign FOX-XP is replaced. If the market expands enough, revenue can grow as share falls. … Show more
Aehr Test Systems is monetizing the test layer of the AI optical interconnect buildout as silicon photonics burn-in reaches production scale. It guided FY2027 revenue to $130-150M, up 160-200% from $50M, after record bookings of $60.7M and a $100.6M effective backlog. Every 800G and 1.6T transceiver and optical I/O chip in AI data centers needs reliability screening, so transceiver growth feeds burn-in demand. Its lead silicon photonics customer keeps reordering and a second is ramping. x.com
Aehr Test Systems' valuation looks ahead of its fundamentals after a strong turnaround quarter. Q4 FY2026 revenue rose 33% to $18.8 million with a return to GAAP profit, bookings hit a record $60.7 million and effective backlog topped $100.6 million. FY2027 guidance of $130-150 million implies 160-200% growth, so the post-earnings run prices in high expectations that depend on shipping FOX-XP systems on schedule without margin erosion. TRT is preferred for now. x.com x.com
Aehr Test Systems has become a key picks-and-shovels supplier to the AI chip boom, with its Sonoma platform the go-to system for reliability testing of high-power AI processors. On April 16, 2026, it announced a $41M follow-on order, its largest ever, from an unnamed hyperscale AI chip leader for custom AI ASIC testing, with revenue from fiscal 2027. Backlog doubled to $38.7M, second-half FY26 bookings exceed $92M, and FY26 should hit the high end of $45-50M guidance. x.com
